Ajax loader
By using our website, you agree to our use of cookies as described in Cookie Policy.

Can't find what you're looking for?

 

Be sure to Sign in to see all available content.

 

If you don't have an account, Register here.

Search results for:

ASTRAZENECA-PFIZER-ANTITRUST
RTR3OX06
May 13, 2014
Pfizer Chief Executive Ian Read leaves after appearing at a parliamentary business and enterprise committee...
London, United Kingdom
Pfizer Chief Executive Ian Read leaves after appearing at a parliamentary business and enterprise committee...
Pfizer Chief Executive Ian Read leaves after appearing at a parliamentary business and enterprise committee hearing at Portcullis House in London May 13, 2014. Read said on Tuesday he did not believe there would be antitrust problems in taking over British drugmaker AstraZeneca. "We don't see any substantial antitrust issues on this deal anywhere in the world," Read told a panel of British lawmakers. REUTERS/Neil Hall (BRITAIN - Tags: BUSINESS POLITICS HEALTH EMPLOYMENT)
Sort by
Display
Items per page
Page
of 1